Monica Jones, MD

Cancer Centers of North Carolina

JonesDr. Jones received her medical education and completed a residency in obstetrics and gynecology at the University of Cincinnati. She then completed a post-doctoral research fellowship in ovarian cancer molecular genetics in the Laboratory of Pathology at the National Cancer Institute. Dr. Jones was then awarded a Foundation for Women’s Cancer/National Cancer Institute Research fellowship permitting her to spend two additional years identifying differentially expressed genes from cDNA libraries derived from borderline and malignant microdissected ovarian cancers. Dr. Jones went on to complete her surgical training in gynecologic oncology at the Mayo Clinic and remained there on staff for five years. During this time she directed a laboratory focused on the functional characterization of a novel steroid regulated growth factor. This work was supported by a Mayo Clinic Surgical Scholar award and later on by an NIH K12 award. Her NIH award also permitted her to complete a Master’s of Science Degree in Clinical Trial Design and translational research.

As an assistant professor at the Mayo Clinic, Dr. Jones not only taught graduate students, medical students, residents and fellows, but Dr. Jones also led the development of patient-focused illustrations and educational materials. She also contributed to the Mayo Clinic Guide to Women’s Cancers and served the Society of Gynecologic Oncology as a member of the education committee. Currently Dr. Jones directs a yearly Women’s Cancer Summit CME program for community physicians and speaks routinely at several community health education events. Dr. Jones is looking forward to advancing the educational mission of the foundation and is honored to be a committee member.


Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.


Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.


The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.


The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.